About Maryland Digestive Disease Research, LLC
"All Capital Digestive Care physicians and advanced practice providers are offering "virtual" visits via telehealth. Call us now to schedule an appointment. We encourage all individuals to practice everyday preventive actions and social-distancing to help prevent the spread of COVID-19."
Clinical Trials at Maryland Digestive Disease Research, LLC
During the past decade, Maryland Digestive Disease Research, LLC conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Maryland Digestive Disease Research, LLC" #1 sponsor was "Biolex Therapeutics, Inc." with 1 trials, followed by "Bristol-Myers Squibb" with 1 trials
sponsored, "Dynogen Pharmaceuticals" with 1 trials sponsored, "Evoke Pharma" with 1 trials sponsored and "Pharmos"
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
Clinical Trials Conditions at Maryland Digestive Disease Research, LLC
According to Clinical.Site data, the most researched conditions in "Maryland Digestive Disease Research, LLC" are
"Irritable Bowel Syndrome" (2 trials), "Delayed Gastric Emptying" (1 trials), "Diabetes" (1 trials), "Diabetes Mellitus" (1 trials) and "Diabetic Gastroparesis" (1 trials). Many other conditions were trialed in "Maryland Digestive Disease Research, LLC" in a lesser frequency.
Clinical Trials Intervention Types at Maryland Digestive Disease Research, LLC
Most popular intervention types in "Maryland Digestive Disease Research, LLC" are "Drug" (6 trials). Other intervention types were less common.
The name of intervention was led by "DDP733" (1 trials), "Dextofisopam" (1 trials), "Entecavir" (1 trials), "Entecavir + Tenofovir" (1 trials) and "Locteron™ (controlled-release interferon alpha 2b)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Maryland Digestive Disease Research, LLC
The vast majority of trials in "Maryland Digestive Disease Research, LLC" are
4 trials for "All" genders and 2 trials for "Female" genders.
Clinical Trials Status at Maryland Digestive Disease Research, LLC
Currently, there are NaN active trials in "Maryland Digestive Disease Research, LLC".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in Maryland Digestive Disease Research, LLC,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Maryland Digestive Disease Research, LLC, 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".